Seer's Proteograph Platform Enables Unprecedented 20,000-Sample...

Seer's Proteograph Platform Enables Unprecedented 20,000-Sample Proteomics Study with Korea University to Develop AI-Driven Diagnostics for Cancers in Young Adults